- Home
- PMVP vs STIM Comparison
PMVP vs STIM Comparison
Compare PMVP & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMVP
- STIM
- Stock Information
- Founded
- PMVP 2013
- STIM 2003
- Country
- PMVP United States
- STIM United States
- Employees
- PMVP N/A
- STIM N/A
- Industry
- PMVP Medicinal Chemicals and Botanical Products
- STIM Medical/Dental Instruments
- Sector
- PMVP Health Care
- STIM Health Care
- Exchange
- PMVP Nasdaq
- STIM Nasdaq
- Market Cap
- PMVP 55.1M
- STIM 232.3M
- IPO Year
- PMVP 2020
- STIM 2018
- Fundamental
- Price
- PMVP $1.25
- STIM $3.56
- Analyst Decision
- PMVP Strong Buy
- STIM Buy
- Analyst Count
- PMVP 1
- STIM 4
- Target Price
- PMVP $5.00
- STIM $6.00
- AVG Volume (30 Days)
- PMVP 230.0K
- STIM 936.2K
- Earning Date
- PMVP 08-07-2025
- STIM 08-11-2025
- Dividend Yield
- PMVP N/A
- STIM N/A
- EPS Growth
- PMVP N/A
- STIM N/A
- EPS
- PMVP N/A
- STIM N/A
- Revenue
- PMVP N/A
- STIM $89,448,000.00
- Revenue This Year
- PMVP N/A
- STIM $105.22
- Revenue Next Year
- PMVP N/A
- STIM $11.89
- P/E Ratio
- PMVP N/A
- STIM N/A
- Revenue Growth
- PMVP N/A
- STIM 22.16
- 52 Week Low
- PMVP $0.81
- STIM $0.52
- 52 Week High
- PMVP $1.82
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- PMVP 64.21
- STIM 46.24
- Support Level
- PMVP $0.96
- STIM $3.18
- Resistance Level
- PMVP $1.36
- STIM $3.60
- Average True Range (ATR)
- PMVP 0.09
- STIM 0.21
- MACD
- PMVP 0.01
- STIM 0.03
- Stochastic Oscillator
- PMVP 72.22
- STIM 86.00
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.